Despite some confusing conclusions among recent findings from the TRAVERSE trial, the results should provide physicians with reassuring evidence to enable them to manage men with symptomatic testosterone deficiency with greater confidence.
No takes yet. Share an insight, caveat, or question.
Hackett et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: